Financials Allied Healthcare Products, Inc.
Equities
AHPIQ
US0192222075
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | 0.00% | 0.00% | -99.00% |
Valuation
Fiscal Period: June | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Capitalization 1 | 11.6 | 9.673 | 7.535 | 47.28 | 16.74 | 6.542 |
Enterprise Value (EV) 1 | 10.6 | 9.537 | 7.34 | 47.07 | 18.1 | 13.8 |
P/E ratio | -5.55 x | -4.38 x | -3.54 x | -15.7 x | 9.93 x | -1.22 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 0.35 x | 0.29 x | 0.24 x | 1.48 x | 0.46 x | 0.24 x |
EV / Revenue | 0.32 x | 0.28 x | 0.23 x | 1.48 x | 0.5 x | 0.51 x |
EV / EBITDA | -11 x | -8.96 x | -3.76 x | -19.3 x | 344 x | -3.34 x |
EV / FCF | 154 x | -103 x | 19.2 x | 55.6 x | -5.65 x | -3.17 x |
FCF Yield | 0.65% | -0.97% | 5.2% | 1.8% | -17.7% | -31.5% |
Price to Book | 0.72 x | 0.69 x | 0.63 x | 5.33 x | 1.58 x | 1.25 x |
Nbr of stocks (in thousands) | 4,014 | 4,014 | 4,014 | 4,014 | 4,014 | 4,014 |
Reference price 2 | 2.890 | 2.410 | 1.878 | 11.78 | 4.170 | 1.630 |
Announcement Date | 9/28/17 | 9/28/18 | 9/27/19 | 9/28/20 | 9/28/21 | 10/7/22 |
Income Statement Evolution (Annual data)
Fiscal Period: Juni | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net sales 1 | 33.51 | 33.76 | 31.38 | 31.89 | 36.28 | 27.05 |
EBITDA 1 | -0.9618 | -1.064 | -1.952 | -2.442 | 0.0526 | -4.129 |
EBIT 1 | -2.052 | -1.996 | -2.774 | -3.062 | -0.5268 | -4.58 |
Operating Margin | -6.12% | -5.91% | -8.84% | -9.6% | -1.45% | -16.93% |
Earnings before Tax (EBT) 1 | -2.052 | -2.019 | -2.08 | -3.144 | 1.76 | -4.762 |
Net income 1 | -2.089 | -2.192 | -2.11 | -3.014 | 1.687 | -5.361 |
Net margin | -6.23% | -6.49% | -6.72% | -9.45% | 4.65% | -19.82% |
EPS 2 | -0.5204 | -0.5500 | -0.5300 | -0.7510 | 0.4200 | -1.340 |
Free Cash Flow 1 | 0.0691 | -0.0925 | 0.3814 | 0.8461 | -3.206 | -4.349 |
FCF margin | 0.21% | -0.27% | 1.22% | 2.65% | -8.84% | -16.08% |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 9/28/17 | 9/28/18 | 9/27/19 | 9/28/20 | 9/28/21 | 10/7/22 |
Balance Sheet Analysis
Fiscal Period: June | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | 1.36 | 7.26 |
Net Cash position 1 | 1 | 0.14 | 0.2 | 0.21 | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | 25.91 x | -1.759 x |
Free Cash Flow 1 | 0.07 | -0.09 | 0.38 | 0.85 | -3.21 | -4.35 |
ROE (net income / shareholders' equity) | -12.1% | -14.5% | -16.3% | -29% | 17.3% | -67.8% |
ROA (Net income/ Total Assets) | -6.09% | -6.75% | -10.6% | -10.9% | -1.76% | -15.3% |
Assets 1 | 34.3 | 32.48 | 19.94 | 27.66 | -95.76 | 35 |
Book Value Per Share 2 | 4.030 | 3.490 | 2.960 | 2.210 | 2.640 | 1.300 |
Cash Flow per Share 2 | 0.2500 | 0.0300 | 0.0500 | 0.6500 | 0.1800 | 0.8300 |
Capex 1 | 0.02 | - | - | 0.62 | 0.17 | 0.08 |
Capex / Sales | 0.06% | - | - | 1.94% | 0.46% | 0.28% |
Announcement Date | 9/28/17 | 9/28/18 | 9/27/19 | 9/28/20 | 9/28/21 | 10/7/22 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-99.00% | 4 | |
+8.07% | 219B | |
+6.59% | 183B | |
+11.26% | 133B | |
+26.57% | 108B | |
+0.65% | 63.06B | |
+13.35% | 52.02B | |
-0.62% | 48.2B | |
-0.93% | 40.37B | |
+11.54% | 39.35B |
- Stock Market
- Equities
- AHPIQ Stock
- Financials Allied Healthcare Products, Inc.